Pharmafile Logo
Pharmafocus logo
Advanced Search
digital_health_weber_shandwick

Internal buy-in is greatest barrier to social media

June 6, 2013
Medical Communications Weber shandwick, digital, social media

Internal challenges – and not regulatory ones – are the biggest barriers to better use of social media in pharma, …

News

Boehringer unveils biopharma plant plan for China

June 6, 2013
Manufacturing and Production Boehringer Ingelheim, China

Boehringer Ingelheim has said it intends to construct a cell-culture biopharmaceutical production facility in China offering contract R&D and manufacturing …

News
Novartis image

Novartis receives FDA warning

June 6, 2013
Manufacturing and Production, Sales and Marketing CGMP, FDA, GMP, Novartis

The FDA has castigated Novartis for what it calls ‘significant violations’ of current good manufacturing practice (CGMP) regulations for finished …

News
Pan appointments image

PAN makes series of appointments and promotions

June 6, 2013
Medical Communications Pan, agency, comms

Creative comms agency PAN has bolstered its team with two new arrivals and three promotions. Vanessa Hume has joined the …

News
kim_sinil_4

Mirna appoints ex-Pfizer senior director

June 6, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA

Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …

Appointment

Bayer takes over Conceptus

June 6, 2013
Sales and Marketing Bayer, Conceptus

The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …

News

Aveo to cut workforce after FDA knock-back

June 6, 2013
Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …

News
johnson and johnson image

J&J recalls 32 million contraceptive packs

June 5, 2013
Manufacturing and Production Cilest, J&J, JJ, recall

Johnson & Johnson has announced a 43-country recall of its oral contraceptive Cilest and suspended production of the drug because …

News

Novartis drug shows cancer promise

June 5, 2013
Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …

News
Celgene image

Celgene predicts trio of blockbusters

June 5, 2013
Sales and Marketing Celgene, Pomalidomide, Revlamid, Velcade

Europe’s medicines committee the CHMP has just adopted a positive opinion for Celgene’s new multiple myeloma treatment Pomalidomide Celgene (pomalidomide). …

News
dave_hunt

HAVAS LYNX makes several leadership changes

June 5, 2013
Medical Communications, Sales and Marketing Creative Lynx, HAVAS LYNX, PM Society Digital Awards

Comms agency HAVAS LYNX has realigned its senior team making a number of changes for the global firm as it …

Appointment
GSK image

GSK licences RA drug

June 5, 2013
Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …

News
astrazeneca image

AstraZeneca abandons late-stage RA drug

June 5, 2013
Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …

News
astrazeneca image

AstraZeneca/BMS drug granted speedy FDA review

June 5, 2013
Sales and Marketing AstraZeneca, BMS, lipodystrophy

AstraZeneca and partner Bristol-Myers Squibb have been granted a priority review for their rare disease drug metreleptin. The medicine is …

News

Sanofi admits $285m failure

June 4, 2013
Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …

News
USP image

USP delays guidance on elemental impurities

June 4, 2013
Manufacturing and Production Q3D, USP

The US Pharmacopeial Convention (USP) has agreed to postpone the deadline for implementing two new chapters on elemental impurities in …

News
Boehringer image

NSCLC lift for Boehringer

June 4, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …

News
Complications combat image

Boehringer and Lilly launch diabetes game

June 4, 2013
Medical Communications Boehringer Ingelheim, combat, lilly

Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …

News
brent_lang

Vocera appoints president and chief executive

June 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera

Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …

Appointment
Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013
Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026